A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of your participation in this study is to help answer the following
research question(s)
- Whether LY2484595 in combination with a statin drug (atorvastatin, simvastatin or
rosuvastatin; currently used to treat abnormal fat or cholesterol in blood) improves the
blood fat profile more than statins alone.
- Whether LY2484595 alone improves blood fats profile compared to sugar pills.
- Whether LY2484595 interferes with break down or functioning of statins.
- Whether LY2484595 has any side effects that would not support testing it in future
studies.